Insider Profile · SEC Form 4 Activity · Trailing 90 Days

Lin Sue-jean

Over the trailing 90 days, Lin Sue-jean (Director at Arcutis Biotherapeutics, Inc.) sold $121K of stock across 2 companies, per 4 SEC Form 4 transactions.

Role: Director
Companies: ARQT STVN
Window: Trailing 90 days · 4 transactions · CIK 1867788
Net activity: −$121K ($0 bought · $121K sold)
Source: Official filings on sec.gov ↗

By Company (Trailing 90 Days)

Symbol	Company	Txns	Bought	Sold	Net
ARQT	Arcutis Biotherapeutics, Inc.	3	—	$121K	−$121K
STVN	Stevanato Group S.p.A.	1	—	—	$0

Transactions (4)

Date	Symbol	Type	Shares	Value	Description
2026-06-15	ARQT	Sell	4.9K	$121K	Open market or private sale
2026-06-12	STVN	Buy	5.0K	$0	Grant, award or other acquisition
2026-06-05	ARQT	Buy	5.8K	$0	Grant, award or other acquisition
2026-06-05	ARQT	Buy	16.7K	$0	Grant, award or other acquisition

Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.

Follow Lin's next move

Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.

Start free